56%, respectively mainly due to the increase of income coupled with the decrease of financing cost. In addition, during 1Q17, its subsidiary (Rajthanee Rojana Hospital Co., Ltd.) has recognized income

profits remain unchanged. Revenue from Sales The company has revenue from sales in the second quarter in the amount of 1,302.1 million Baht increased by 1.2 percent compared to the same quarter of the

reduce in value, although the net profits remain unchanged. Revenue from Sales The company has revenue from sales in the third quarter in the amount of 1,267.6 million Baht decreased by 12.8 percent

deteriorate from 36% to 32% of revenue. This was not only attributed to the decrease of SW revenue but also from the rising cost of SW patients. Number of insurers increased and consequently more visits of SW

15% and 14% yoy, respectively. In 2Q’18, the company’s gross margin was 28% of revenue in line with previous year. The unchanged gross margin of 2Q’18 was due to high revenue base of 2Q’17 following

% compared to the same period of 2018. In March 2019, China produced crude steel at 80.3 million tons up by 10.0%, India produced crude steel at 9.4 Mt decreased by 1.0%, Japan at 9.1 Mt unchanged from same

: 1. Sales Revenue 1.1 Sales revenue for the 3-months period ended 31 October 2019 For the 3-months period ended 31 October 2019, INGRS registered sales revenue of Baht 695.34 million, a decrease by

performance of the Group Unit: Million Baht 2019 2018 Increase (decrease) Variance (%) Total revenues 6,797 8,080 (1,283) (16%) Net profit 331 526 (195) (37%) The Group’s total revenues for 2019 amounted Baht

decrease of 87.66 million Baht from the same quarter last year which was equal to 165.55 million Baht, representing a decrease of 52.95 percent, of which the total decrease in revenue mainly came from sales

Baht, a decrease of 87.66 million Baht from the same quarter last year which was equal to 165.55 million Baht, representing a decrease of 52.95 percent, of which the total decrease in revenue mainly came